Have you been diagnosed with advanced unresectable pancreatic cancer. If so, you may be able to take part in a research study looking at the safety and tolerability of olaparib in combination with durvalumab and radiation therapy in patients with pancreatic cancer.

Have you been diagnosed with locally advanced head and neck squamous cell carcinoma? If so, you may be able to participate in a research study to evaluate whether pembrolizumab and olaparib given before and after chemoradiotherapy can improve 1-year progression free survival.

African American communities have been disproportionately affected by the burdens of cancer, yet their experiences and voices remain underrepresented in health research. In this study, we want to understand the experiences and perspectives of African American/Black individuals who support or care for their loved ones diagnosed with cancer.

Do you have a newly diagnosed endometrial cancer? if so, you may be eligible to participate in a research study looking at the role the uterine and gut microbiomes play in endometrial cancer development and treatment.

Have you been diagnosed with multiple myeloma that has returned and needed to be treated again? If so, you may be able to take part in a research study looking at the safety of giving a new drug called REGN5458 (Linvoseltamab) to patients with relapsed/refractory multiple myeloma.

In this study, we want to hear from patients with metastatic breast cancer about how their oncologists speak with them about their prognosis. We know these conversations can be challenging, and we want to hear from patients and caregivers about what is helpful or not helpful in those conversations. We also want to hear from patients about a breast cancer-specific tool.

In this study we want to learn more about the factors that affect quality of life for breast cancer survivors. We also want to learn about the common experiences patients face. What we learn in this study could be used in future research to address overlooked challenges for patients in life after treatment.

The purpose of this study is to increase the involvement of black breast cancer patients in clinical research trials and connect these patients with resources.

In this study, we want to understand the experiences of Black women in their journey to a diagnosis of endometrial cancer. Learning more about the diagnosis experience will help us to understand what made it easy or difficult to get their diagnosis. This information will help us to develop a tool to improve the endometrial cancer diagnosis experience.

Researchers are trying to find out if they can slow the growth of prostate cancer by adding green tea to patients treatment. Researchers are also trying to find out if this could be better or worse than usual care patients get.